Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib

Bull Cancer. 2019 Jan;106(1):84-85. doi: 10.1016/j.bulcan.2018.11.011. Epub 2018 Dec 19.

Authors

Laurys Boudin¹, Matthieu Patient², Precilla Tsitsi Nding Tsogou³, Emilie Roméo³, Jean-Sébastien Bladé³, Jean-Pierre de Jauréguiberry²

Affiliations

¹ Hôpital d'instruction des armées Sainte-Anne, service de médecine interne-oncologie, boulevard Sainte-Anne, 83000 Toulon, France. Electronic address: laurys84@hotmail.com.
² Hôpital d'instruction des armées Sainte-Anne, service de médecine interne-oncologie, boulevard Sainte-Anne, 83000 Toulon, France; École du Val-de-Grâce, boulevard Port-Royal, 75005 Paris, France.
³ Hôpital d'instruction des armées Sainte-Anne, service de médecine interne-oncologie, boulevard Sainte-Anne, 83000 Toulon, France.

PMID: 30579570
DOI: 10.1016/j.bulcan.2018.11.011

No abstract available

Keywords: Chronic hepatitis E; Chronic lymphocytic leukemia; Ibrutinib; Ribavirine.

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives
Aged
Alemtuzumab / therapeutic use
Antineoplastic Agents, Immunological / therapeutic use
Antiviral Agents / therapeutic use*
Chronic Disease
Disease Progression
Hepatitis E / complications
Hepatitis E / diagnosis
Hepatitis E / drug therapy*
Hepatitis E / virology
Hepatitis E virus / drug effects
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / complications
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Leukemia, Lymphocytic, Chronic, B-Cell / genetics
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Male
Piperidines
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*
Ribavirin / therapeutic use*

Substances

Antineoplastic Agents, Immunological
Antiviral Agents
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Alemtuzumab
Ribavirin
Adenine